v3.26.1
EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2026
57,994,08721,400,00079,394,087$0.95 
Balance as of March 31, 2026
57,994,08721,400,00079,394,087$0.95 
Exercisable as of March 31, 2026
56,624,08721,400,00078,024,087$0.96 
Schedule of Stock Options Outstanding
The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202626,597,918 $0.75 
Cancelled/forfeited/expired(56,666)$0.66 
Issued and Outstanding as of March 31, 202626,541,252 $0.75 
Exercisable as of March 31, 202619,465,889 $0.83 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Three Months Ended March 31,
20262025
Weighted average stock price$0.29
Weighted average expected stock price volatility92.0%
Expected annual dividend yield0%
Weighted average expected life5.0 years
Weighted average risk-free annual interest rate4.0%
Weighted average grant date fair value$0.21
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense, net, are as follows:
Three Months Ended March 31,
20262025
Stock options expense (forfeiture)
$265 $(381)
Restricted stock68 — 
Warrants59 74 
Total share-based compensation expense (forfeiture), net
$392 $(307)